Gary Charles Robb - Sep 1, 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Stock symbol
CORT
Transactions as of
Sep 1, 2023
Transactions value $
$16,550
Form type
4
Date filed
9/6/2023, 06:15 PM
Previous filing
Jun 16, 2023
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Award $16.6K +500 +2.5% $33.10 20.5K Sep 1, 2023 Direct F1, F2, F3
transaction CORT Common Stock Award $0 +500 +2.44% $0.00 21K Sep 1, 2023 Direct F3, F4
holding CORT Common Stock 8.06K Sep 1, 2023 Custodial Account for Child F5
holding CORT Common Stock 8.06K Sep 1, 2023 Custodial Account for Child F5
holding CORT Common Stock 8.06K Sep 1, 2023 Custodial Account for Child F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023.
F2 In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
F3 Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F4 Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
F5 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.